What is more, Wu et al. observed that following ZEB1 downregulation it was possible to suppress EMT in Ishikawa cell line derived from endometrial adenocarcinoma, which suggests a new potential therapeutic target [43]. Here, ZEB1 is linked to endometrium adenocarcinoma.